CXCL8 and cancer: Professor Kiyohiko Hatake’s research group at the Japanese Foundation of Cancer Research has dedicated decades to investigating this phenomenon and has reported that when leukemic cells attach to vascular endothelial cells, CD13 facilitates the degradation of the pro-apoptotic cytokine IL-8 produced by the endothelium [83,84].